Open Insider Trading Activity for Intellia Therapeutics, Inc. VP, Chief Accounting Officer Dube Michael P
31-day price and insider activity (up to 2 years)
Daily candles with triangles for the buy and sale transactions shown below. Scroll left or zoom out to load earlier candles (up to 2 years).
▲ Insider buy
▼ Insider sale
Loading daily price history…
Charting by TradingView Lightweight Charts
| Ticker | Filing Date | Transaction Date | Company | Insider | Title | Transaction | Trade Count | Shares | Avg. Price | Total Value | Position Size Change | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tax liability coverage transfers: shares are often sold to offset the tax liability from shares vesting NTLA | 2026-10-06 | 2026-10-02 | Intellia Therapeutics, Inc. | Dube Michael P | VP, Chief Accounting Officer | Sell | 1 | 1,864 | $12.43 | $23,169.52 | 2.79% | View Filing |
| Tax liability coverage transfers: shares are often sold to offset the tax liability from shares vesting NTLA | 2025-01-07 | 2025-01-03 | Intellia Therapeutics, Inc. | Dube Michael P | VP, Chief Accounting Officer | Sell | 1 | 1,372 | $12.18 | $16,710.96 | 2.92% | View Filing |